Feasibility and validity of a one-item fatigue screen in a thoracic oncology clinic

Journal of Thoracic Oncology

Volumn 1, Issue 5, 2006, Pages 454-459

  Temel, Jennifer S ^a   Pirl, William F ^a   Recklitis, Christopher J ^b   Cashavelly, Barbara ^a   Lynch, Thomas J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Fatigue; Lung cancer; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FATIGUE; FATIGUE SYMPTOM INVENTORY; FEASIBILITY STUDY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE SCALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; ONE ITEM FATIGUE SCALE; OUTPATIENT; PREDICTIVE VALIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; TEST RETEST RELIABILITY; VALIDITY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; THORAX TUMOR; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; THORACIC NEOPLASMS;

EID: 34247268281     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01243894-200606000-00013     Document Type: Article

References (40)

1. Glaus A, Crow R, Hammond S. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Eur J Cancer Care 1996;5(2 Suppl):8-23.
2. Clinical practice guidelines in oncology: cancer-related fatigue. National Comprehensive Cancer Network. Available at www.nccn.org. Accessed December 30, 2005.
3. Vogelzang NJ, Breitbart W, Cella D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997;34(3 Suppl 2):4-12.
4. Portenoy RK, Thaler HT, Kornblith AB, et al. Symptom prevalence, characteristics and distress in a cancer population. Quality Life Res 1994;3:183-189.
5. Vainio A. Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Sympt Manage 1996;12:3-10.
6. Iop A, Manfredi AM, Bonura S. Fatigue in cancer patients receiving chemotherapy: an analysis of published studies. Ann Oncol 2004;15:712-720.
7. Stone P, Richards M, A'Hern R, Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 2000;11:561-567.
8. Carlson LE, Angen M, Cullum J, et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer 2004;90:2297-2304.
9. Okuyama T, Tanaka K, Akechi T, et al. Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening. J Pain Sympt Manage 2001;22:554-564.
10. Spelten ER, Verbeek JH, Uitterhoeve AL, et al. Cancer, fatigue and the return of patients to work-a prospective cohort study. Eur J Cancer 2003;39:1562-1567.
11. Curt GA, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 2000;5:353-360.
12. Dillon E, Kelly J. The status of cancer fatigue on the Island of Ireland: AIFC professional and interim patient surveys. Oncologist 2003;8 Suppl 1:22-26.
13. Passik SD. Impediments and solutions to improving the management of cancer-related fatigue. J Natl Cancer Inst Monogr 2004;32:136.
14. Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol 2000;11:971-975.
15. Passik SD, Kirsh KL, Donaghy K, et al. Patient-related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaire. J Pain Sympt Manage 2002;24:481-493.
16. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999;85:1186-1196.
17. Hwang SS, Chang VT, Cogswell J, Kasimis BS. Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center. Cancer 2002;94:2481-2489.
18. Piper BF, Dodd MJ, Ream E Improving the clinical measurement of cancer-related fatigue. In: Better Health Through Nursing Research: International State of the Science, American Nurses Association, 1999.
19. Cella D. Functional assessment of chronic illness therapy. Available at http://www.facit.org. Accessed December 30, 2005.
20. Hann DM, Denniston MM, Baker F. Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory. Qual Life Res 2000;9:847-854.
21. Carroll BT, Kathol RG, Noyes RWald TG, Clamon GH. Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hospit Psychiatry 1993;15:69-74.
22. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley-Interscience, 2000.
23. Max, MB. Improving outcomes of analgesic treatment: is education enough? Ann Intern Med 1990;113:885-889.
24. Du Pen SL, Du Pen AR, Polissar N, et al. Implementing guidelines for cancer pain management: results of a randomized controlled clinical trial. J Clin Oncol 1999;17:361-370.
25. Jacobsen PB, Donovan KA, Weitzner MA. Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsychiatry 2003;8:229-240.
26. Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 1998;16:3412-3425.
27. Dimeo F, Fetscher S, Lange W, Mertelsmann R, Keul J. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood 1997;90:3390-3394.
28. Dimeo F, Stieglitz RD, Novelli-Fischer U, Fetscher S, Mertelsmann R, Keul J. Correlation between physical performance and fatigue in cancer patients. Ann Oncol 1997;8:1251-1255.
29. Dimeo FC, Tilmann MH, Bertz H, Kanz L, Mertelsmann R, Keul J. Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation. Cancer 1997;79:1717-1722.
30. Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 1997;15:1218-1234.
31. MacVicar MG, Winningham ML, Nickel JL. Effects of aerobic interval training on cancer patients' functional capacity. Nurs Res 1989;38:348-351.
32. Mock V, Dow KH, Meares CJ, et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997;24:991-1000.
33. Mock V, Pickett M, Ropka ME, et al. Fatigue and quality of life outcomes of exercise during cancer treatment [see comments.]. Cancer Pract 2001;9:119-127.
34. Schwartz AL. Fatigue mediates the effects of exercise on quality of life. Qual Life Res 1999;8:529-538.
35. Segal R, Evans W, Johnson D, et al. Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol 2001;19:657-665.
36. Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer [comments]. J Clin Oncol 2003;21:1653-1659.
37. Winningham ML. Strategies for managing cancer-related fatigue syndrome: a rehabilitation approach. Cancer 2001;92(4 Suppl):988-997.
38. Winningham ML, Nail LM, Burke MB, et al. Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 1994;21:23-36.
39. Hwang SS, Chang VT, Rue M, Kasimis B. Multidimensional independent predictors of cancer-related fatigue. J Pain Sympt Manage 2003;26:604-614.
40. Smith EM, Gomm SA, Dickens CM. Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliat Med 2003;17:509-513.